Francisco R. Velázquez, M.D., S.M., president and chief executive officer for PAML, LLC and PAML Ventures, will be speaking about consumerism in healthcare during the 2015 California Clinical Laboratory Association (CCLA) Annual Conference, scheduled for November 4-6, 2015 at the Westin South Coast Plaza Hotel in Costa Mesa, CA. The conference will address issues on Medicare coverage and reimbursement, Medi-Cal, PAMA, MolDx Re-Coding, and the framework for oversight on state and federal legislation impacting the industry.

Dr. Velázquez’ presentation, scheduled for Friday, November 6, 2015 from 9:15 to 10:00 a.m., will examine the growing trends in consumer-driven healthcare products and services. He will discuss enablers for consumer-oriented products and services, including technological enablers and non-traditional methods of care. He will also touch on intergenerational transition, enabling the transition from traditional services to distributed services—which take advantage of non-traditional models, providers, and tools.

According to Velázquez, “Traditionally, healthcare has relied on a centralized model in which the institution and provider determine the mode, extent, and timing of services. A number of factors are influencing the way consumers participate in healthcare, such as increasing out-of-pocket costs, tools and technology that improve access and provide content and information, the ability for broad distribution of information enabled by social media, and the intergenerational transition between baby boomers and millennials. All of these are changing the expectation of consumers to a model in which full participation, immediate access, transactional ease, and low cost prevail.” The presentation will cover consumer trends influencing healthcare, technological enablers, and disruptive participants such as employers, retail and technology companies. Specific examples will be provided and the intergenerational transition to millennials and globalism will be explored. Although policy and law has not impacted these consumer trends as of yet, Dr. Velázquez envisions specific acts of law to address these gaps, one current example being the different state-based laws that govern direct-to-consumer testing (DTC). He will be reviewing examples of current policy and discuss potential future requirements as part of the presentation.

Dr. Velázquez is an experienced physician executive with a strong clinical background and excellent business leadership skills. He trained at the Mallory Institute of Pathology in Boston and holds a master’s degree in Healthcare Management & Policy from Harvard University. Prior to PAML, he served as managing director of Nichols Institute and managing director/vice president for Focus Diagnostics, both a part of Quest in California. He had direct oversight for the reference laboratory testing business at both laboratories as well as the clinical trials at Focus Diagnostics. Nichols Institute and Focus Diagnostics have both been selected as Top Places to work in Orange County (California) for three consecutive years. Other previous experience includes executive, faculty and medical leadership roles at universities in Texas, New York, Michigan and Massachusetts.